From The Lab To The Production Plant
Drug companies turn to contract manufacturers for help in commercializing small-molecule drugs
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
March 3, 2014 Cover
Volume 92, Issue 9
Drug companies turn to contract manufacturers for help in commercializing small-molecule drugs
Cover image:
Credit:
Drug companies turn to contract manufacturers for help in commercializing small-molecule drugs
Max Planck Institute for Coal Research celebrates 100 years
Pending bills target specific chemicals but also eye establishment of substances of concern lists
New drug prospects target inflammation as research highlights complexity of the condition
Biotech firms overcome technical challenges to make fiber stronger than steel and tougher than Kevlar
After failing to live up to its original promises, method proves useful for determining atom connectivity